Sign inSign up

ADSA Society

Logo
IssuesFor AuthorsAdvertisingNewsHelp

ADSA Society

Search Results

You are looking at 1-10 of 59

Figure 1; Pathophysiology of nausea and vomiting. Vomiting is caused by noxious stimulation of the vomiting center directly or indirectly via 1 or more of 4 additional sites: the gastrointestinal (GI) tract, the vestibular system, the chemoreceptor trigger zone, and higher centers in the cortex and thalamus. Once receptors are activated, neural pathways lead to the vomiting center, where emesis is initiated. Neural traffic originating in the GI tract travels along afferent fibers of cranial nerves IX (glossopharyngeal) and X (vagal). Antiemetic targets for drug interventions are predicated on their ability to block the illustrated receptor sites. Receptors illustrated along with their conventional ligands are as follows: H1 histamine, M1 acetylcholine, 5-HT3 serotonin, DA2 dopamine, NK1 (neurokinin) substance P, and mu/kappa opioids. Transmitter mediators in the cerebral cortex and thalamus are poorly understood, although cortical cannabinoid (CB1) pathways have been characterized.
Daniel E. Becker
Figure 1
Figure 1

Pathophysiology of nausea and vomiting. Vomiting is caused by noxious stimulation of the vomiting center directly or indirectly via 1 or more of 4 additional sites: the gastrointestinal (GI) tract, the vestibular system, the chemoreceptor trigger zone, and higher centers in the cortex and thalamus. Once receptors are activated, neural pathways lead to the vomiting center, where emesis is initiated. Neural traffic originating in the GI tract travels along afferent fibers of cranial nerves IX (glossopharyngeal) and X (vagal). Antiemetic targets for drug interventions are predicated on their ability to block the illustrated receptor sites. Receptors illustrated along with their conventional ligands are as follows: H1 histamine, M1 acetylcholine, 5-HT3 serotonin, DA2 dopamine, NK1 (neurokinin) substance P, and mu/kappa opioids. Transmitter mediators in the cerebral cortex and thalamus are poorly understood, although cortical cannabinoid (CB1) pathways have been characterized.


Nausea, Vomiting, and Hiccups: A Review of Mechanisms and Treatment
Daniel E. Becker DDS
Article Category: Research Article
Volume/Issue: Volume 57: Issue 4
Online Publication Date: Jan 01, 2010
DOI: 10.2344/0003-3006-57.4.150
Page Range: 150 – 157

vestibular system, the chemoreceptor trigger zone, and higher centers in the cortex and thalamus. Once receptors are activated, neural pathways lead to the vomiting center, where emesis is initiated. Neural traffic originating in the GI tract travels along afferent fibers of cranial nerves IX (glossopharyngeal) and X (vagal). Antiemetic targets for drug interventions are predicated on their ability to block the illustrated receptor sites. Receptors illustrated along with their conventional ligands are as follows: H 1 histamine, M 1 acetylcholine, 5-HT 3 serotonin, DA 2

Download PDF
Emi Ishikawa DDS,
 Rie Iwamoto DDS, PhD,
 Takayuki Hojo DDS, PhD,
 Takahito Teshirogi DDS,
 Keiji Hashimoto DDS,
 Makiko Shibuya DDS, PhD,
 Yukifumi Kimura DDS, PhD, and
 Toshiaki Fujisawa DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 69: Issue 1
Online Publication Date: Apr 04, 2022
Page Range: 18 – 23

Postoperative nausea and vomiting (PONV) is one of the most frequent postoperative complications that can delay recovery after general anesthesia. The incidence of PONV after oral surgery has been reported as ∼24 to 46% 1 , 2 and is especially high after orthognathic surgery, approximating 40% to 73%. 1 – 3 Anesthesia-specific factors related to PONV include the use of general anesthesia, selection of specific anesthetic agents, 4 , 5 and prophylactic administration of antiemetics. 4 , 6 According to a meta-analysis that included

Regina A. E. Dowdy DDS, MS,
 Sarah Forgy DDS,
 Oussama Hefnawi DDS, and
 Tiffany A. Neimar DDS
Article Category: Other
Volume/Issue: Volume 70: Issue 3
Online Publication Date: Oct 18, 2023
Page Range: 142 – 153

multimodal approach potentiating minimal and moderate sedation without the risk of major respiratory depression when used within recommended dosing ranges. An added benefit with antihistamines is their anticholinergic and antiemetic effects. The antiemetic effects are most evident with promethazine; however, all of the antihistamine agents discussed here display anticholinergic effects including antisialagogue effects, increased heart rate, and slowed GI motility. Diphenhydramine Available as an over-the-counter medication, diphenhydramine is a

Rumi Kaneko DDS,
 Kyotaro Koshika DDS, PhD,
 Mai Shionoya DDS,
 Kotaro Shimizu DDS,
 Yuka Sendai DDS,
 Nobutaka Matsuura DDS, and
 Tatsuya Ichinohe DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 71: Issue 1
Online Publication Date: May 03, 2024
Page Range: 3 – 7

intermaxillary fixation, vomiting may cause serious complications such as airway obstruction and pulmonary aspiration. To reduce these risks, general anesthesia for orthognathic surgery at our institution is often maintained with a combination of propofol and remifentanil. Propofol has antiemetic effects, 5 and remifentanil can reduce intraoperative bleeding by reducing oral tissue blood flow due to potent hypotensive effects and less peripheral vasodilation. 6 – 10 Propofol reduces the incidence of PONV compared with inhaled anesthetics. 11 , 12 However, it has been

Kyle J. Kramer DDS, MS
Article Category: Editorial
Volume/Issue: Volume 67: Issue 3
Online Publication Date: Sep 29, 2020
Page Range: 125 – 126

In February 2019, the pharmaceutical manufacturer, American Regent, Inc (Shirley, NY) reintroduced droperidol to the US drug market. Droperidol is a butyrophenone, the same drug class as the typical antipsychotic agent haloperidol, and acts as a dopamine D2 receptor antagonist producing antiemetic and sedative-hypnotic effects. Not only has it been used along with fentanyl to produce a state of neuroleptic analgesia, previously marketed in combination as Innovar (Janssen Pharmaceutica, Beerse, Belgium) and since discontinued, but it also has

Article Category: Other
Volume/Issue: Volume 61: Issue 4
Online Publication Date: Dec 01, 2014
Page Range: 184 – 184

Acute angle-closure glaucoma, 155 Adrenal hypoplasia, 158 Adrenaline, 150 Adverse drug reactions, 26 Airway fire, 21 Airway management, 78, 113, 162 Anesthesia, 63, 164 Anesthesiology, 3 Anti-emetic prophylaxis, 18 Antipsychotics, 150 Appropriate head position, 47 ATP, 95 Bolus infusion, 18 Calcium channel antagonist, 18 Cavity, 111 Central adenosine receptors, 95 Cerebrovascular event, 73 Complication, 73

Silvina Friedlander Barenboim DMD,
 Vladislav Dvoyris, and
 Eliezer Kaufman DMD
Article Category: Research Article
Volume/Issue: Volume 56: Issue 1
Online Publication Date: Jan 01, 2009
Page Range: 3 – 8

during antineoplastic treatment or post surgery, yet some are used to minimize nausea at pregnancy. Their therapeutic activity is incomplete, as it depends on genetic polymorphism of 5-HT 3 receptors. 15 The objective of this study was to examine the prophylactic effect of granisetron, a commonly used antiemetic drug, during palatal and oropharyngeal stimulation mimicking the dental situation, as a first step in establishing a protocol for extensive gaggers. Methods Subjects and Study Design This study was

Mark A. Saxen DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 70: Issue 2
Online Publication Date: Jun 28, 2023
Page Range: 106 – 108

dexamethasone on the prevention of postoperative nausea and vomiting in gynaecological day surgery under remimazolam-based general anesthesia. Medicine (Baltimore). 2023;102(10):e33249. doi: 10.1097/MD.0000000000033249 . This study examined the effectiveness of low-dose propofol combined with dexamethasone for preventing postoperative nausea and vomiting (PONV) in women undergoing total intravenous anesthesia for ambulatory gynecologic surgery with remimazolam and alfentanil. Three antiemetic regimens were compared: dexamethasone 5 mg alone, dexamethasone 5 mg

Allison L. Spera DMD, MS,
 Mark A. Saxen DDS, PhD,
 Juan F. Yepes DDS, MD, MPH, MS, DrPH,
 James E. Jones DMD, MSD, EdD, PhD, and
 Brian J. Sanders DDS, MS
Article Category: Research Article
Volume/Issue: Volume 64: Issue 3
Online Publication Date: Jan 01, 2017
Page Range: 144 – 152

obstructive sleep apnea. Two hundred forty-eight (3.52%) reported a pulmonary comorbidity. Of the 7041 cases, 4712 patients (66.9%) received dexamethasone, 3967 (56.3%) received a serotonin receptor antagonist, and 4 (0.06%) received another antiemetic either prior to or during the case. The most common airway management technique used was nasal/oral airway, reported in 4459 cases (63.3%; Table 2 ). Table 2 Airway Management Techniques* Of the 7041 cases, 5521 patients

ANPR logo
AboutIssuesAuthor InformationSubscriptions

ADSA Society

eISSN: 1878-7177

ISSN: 0003-3006

Powered by PubFactory